Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics
Top Cited Papers
- 31 March 2007
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 46 (3), 474-481
- https://doi.org/10.1016/j.jhep.2006.10.020
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999
- Liver abscess formation after local treatment of liver tumorsHepatology, 1996
- Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization feverJournal of Hepatology, 1995
- Pharmacokinetics and toxicity of intraarterial Adriamycin for hepatocellular carcinoma: Effect of coadministration of lipiodolJournal of Hepatology, 1991
- Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycinJournal of Hepatology, 1990
- Hepatic extraction of adriamycin in patients with hepatocellular carcinomaEuropean Journal of Cancer and Clinical Oncology, 1984